157 related articles for article (PubMed ID: 37565087)
1. Embolic Agents: Particles.
Lee S; Ghosh A; Xiao N; Gordon AC; Heidarpour N; Funaki B; Lewandowski RJ
Semin Intervent Radiol; 2023 Jun; 40(3):315-322. PubMed ID: 37565087
[No Abstract] [Full Text] [Related]
2. Evaluation of particulate embolic materials with MR imaging, scanning electron microscopy, and phase-contrast microscopy.
Nakabayashi K; Negoro M; Handa T; Keino H; Takahashi M; Sugita K
AJNR Am J Neuroradiol; 1997 Mar; 18(3):485-91. PubMed ID: 9090408
[TBL] [Abstract][Full Text] [Related]
3. Embolic agents used for bronchial artery embolisation in massive haemoptysis.
Yoon W
Expert Opin Pharmacother; 2004 Feb; 5(2):361-7. PubMed ID: 14996632
[TBL] [Abstract][Full Text] [Related]
4. Determining the quantity and character of carotid artery embolic debris by electron microscopy and energy dispersive spectroscopy.
DeRubertis BG; Chaer RA; Gordon R; Bell H; Hynecek RL; Pieracci FM; Karwowski J; Kent KC; Faries PL
J Vasc Surg; 2007 Apr; 45(4):716-24; discussion 724-5. PubMed ID: 17306955
[TBL] [Abstract][Full Text] [Related]
5. Particle Distribution in Embolotherapy, How Do They Get There? A Critical Review of the Factors Affecting Arterial Distribution of Embolic Particles.
Talaie R; Torkian P; Amili O; Aboufirass Y; Rostambeigi N; Jalaeian H; Golzarian J
Ann Biomed Eng; 2022 Aug; 50(8):885-897. PubMed ID: 35524027
[TBL] [Abstract][Full Text] [Related]
6. Novel magnetic embolic MRI imageable particles with anticancer drug release for transcatheter arterial embolization and magnetic ablation.
Bekaroğlu MG; Nurili F; Caymaz İ; Baş A; İşçi S
Med Phys; 2023 Apr; 50(4):1990-1998. PubMed ID: 36305489
[TBL] [Abstract][Full Text] [Related]
7. Arterial distribution characteristics of Embozene particles and comparison with other spherical embolic agents in the porcine acute embolization model.
Stampfl S; Bellemann N; Stampfl U; Sommer CM; Thierjung H; Lopez-Benitez R; Radeleff B; Berger I; Richter GM
J Vasc Interv Radiol; 2009 Dec; 20(12):1597-607. PubMed ID: 19944985
[TBL] [Abstract][Full Text] [Related]
8. Determination of size of aortic emboli and embolic load during coronary artery bypass grafting.
Barbut D; Yao FS; Lo YW; Silverman R; Hager DN; Trifiletti RR; Gold JP
Ann Thorac Surg; 1997 May; 63(5):1262-7. PubMed ID: 9146312
[TBL] [Abstract][Full Text] [Related]
9. Histopathologic appearance of arterial occlusions with hydrogel and polyvinyl alcohol embolic material in domestic swine.
Link DP; Strandberg JD; Virmani R; Blashka K; Mourtada F; Samphilipo MA
J Vasc Interv Radiol; 1996; 7(6):897-905. PubMed ID: 8951758
[TBL] [Abstract][Full Text] [Related]
10. A percutaneous aortic device for cerebral embolic protection during cardiovascular intervention.
Carpenter JP; Carpenter JT; Tellez A; Webb JG; Yi GH; Granada JF
J Vasc Surg; 2011 Jul; 54(1):174-181.e1. PubMed ID: 21236621
[TBL] [Abstract][Full Text] [Related]
11. Modification of embolic-PVA particles with MR contrast agents.
Cilliers R; Song Y; Kohlmeir EK; Larson AC; Omary RA; Meade TJ
Magn Reson Med; 2008 Apr; 59(4):898-902. PubMed ID: 18383280
[TBL] [Abstract][Full Text] [Related]
12. Determinants of embolic risk during angioplasty and stenting: neurologic symptoms and coronary artery disease increase embolic risk.
Chung C; Shah TR; Shin H; Han D; Marin ML; Faries PL
Ann Surg; 2010 Oct; 252(4):618-24. PubMed ID: 20881768
[TBL] [Abstract][Full Text] [Related]
13. Reduction of Cerebral Emboli: In vitro Study with a Novel Cerebral Embolic Protection Device.
Haiman G; Nazif T; Moses JW; Ashkenazi A; Margolis P; Lansky AJ
Med Devices (Auckl); 2020; 13():67-73. PubMed ID: 32210643
[TBL] [Abstract][Full Text] [Related]
14. Magnetic mesoporous embolic microspheres in transcatheter arterial chemoembolization for liver cancer.
Liu L; Liang X; Xu X; Zhang X; Wen J; Chen K; Su X; Teng Z; Lu G; Xu J
Acta Biomater; 2021 Aug; 130():374-384. PubMed ID: 34082098
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin Drug-Eluting Embolic Chemoembolization of Hepatocellular Carcinoma: Study of Midterm Doxorubicin Delivery in Resected Liver Specimens.
D'inca H; Piot O; Diebold MD; Piardi T; Marcus C; Burde F; Sommacale D; Manfait M; Thiéfin G
J Vasc Interv Radiol; 2017 Jun; 28(6):804-810. PubMed ID: 28532743
[TBL] [Abstract][Full Text] [Related]
16. Looking for the ideal particle: an experimental embolization study.
Senturk C; Cakir V; Yorukoglu K; Yilmaz O; Goktay AY
Cardiovasc Intervent Radiol; 2010 Apr; 33(2):336-45. PubMed ID: 19915900
[TBL] [Abstract][Full Text] [Related]
17. Initial experience with the 5 × 300-mm Proteus embolic capture angioplasty balloon in the treatment of peripheral vascular disease.
Zeller T; Schmidt A; Rastan A; Noory E; Sixt S; Scheinert D
J Endovasc Ther; 2012 Dec; 19(6):826-33. PubMed ID: 23210883
[TBL] [Abstract][Full Text] [Related]
18. Biocompatibility and recanalization characteristics of hydrogel microspheres with polyzene-F as polymer coating.
Stampfl S; Stampfl U; Bellemann N; Sommer CM; Thierjung H; Radeleff B; Lopez-Benitez R; Berger I; Kauffmann GW; Richter GM
Cardiovasc Intervent Radiol; 2008; 31(4):799-806. PubMed ID: 18214594
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of tris-acryl gelatin microsphere embolization with monochromatic X Rays: comparison with polyvinyl alcohol particles.
Yamamoto A; Imai S; Kobatake M; Yamashita T; Tamada T; Umetani K
J Vasc Interv Radiol; 2006 Nov; 17(11 Pt 1):1797-802. PubMed ID: 17142710
[TBL] [Abstract][Full Text] [Related]
20. Predicting embolic potential during carotid angioplasty and stenting: analysis of captured particulate debris, ultrasound characteristics, and prior carotid endarterectomy.
Malik RK; Landis GS; Sundick S; Cayne N; Marin M; Faries PL
J Vasc Surg; 2010 Feb; 51(2):317-22. PubMed ID: 20006918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
